Discover trends, market shifts, and competitive outlooks for the veterinary oncology industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has the Veterinary Oncology Market Growth Performance Trended Historically, And What Lies Ahead?

In recent years, the market size of veterinary oncology has experienced significant growth. It is projected to expand from $0.4 billion in 2024 to $0.45 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 12.3%. The growth that occurred in the historic period is largely due to factors such as a rise in pet ownership, the humanization of pets, the transfer of knowledge from human oncology, growing cognizance of pet health, and advancements in pharmaceuticals.

In the upcoming years, the market size of veterinary oncology is projected to experience swift expansion. It is anticipated to leap to $0.69 billion by 2029, with a compound annual growth rate (CAGR) of 11.0%. Factors such as the rise in personalized animal medication, an increase in cancer prevalence among animals, an ageing pet population, improved access to specialist care, along with regulatory support and authorizations, contribute to the anticipated growth during the forecast period. Leading trends during this forecast period encompass innovative diagnostic technologies, personalized treatment strategies, progress in immunotherapy, targeted therapies, and the use of telemedicine in oncology discussions.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9533&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Veterinary Oncology Market?

The increased incidence of cancer among pets is anticipated to fuel the growth of the veterinary oncology market. Cancer, a disease marked by unchecked cell proliferation that subsequently spreads to other parts of the body, has similar physical symptoms in pets, including tumors and swelling. Veterinary oncology, therefore, aims to diagnose and treat these cancers in animals, aiming to curtail disease spread and metastasis. Thus, a rise in cancer cases among pets creates a high demand for veterinary oncology. As per The Cancer Letter, a publication based in the US that specializes in cancer research, approximately 6 million pet dogs in the US will contract cancer by 2024. In addition, the British Small Animal Veterinary Association (BSAVA), a veterinary group from the UK, estimated in November 2023 that 1 in 4 dogs and 1 in 5 cats are likely to receive a cancer diagnosis in their lifetime. Consequently, this mounting pet cancer incidence is propelling the veterinary oncology market forward.

Which Primary Segments of the Veterinary Oncology Market Are Driving Growth and Industry Transformations?

The veterinary oncology market covered in this report is segmented –

1) By Therapy: Surgery, Radiology, Chemotherapy, Other Therapies

2) By Animal Type: Equine, Canine, Feline, Other Animal Types

3) By Cancer Type: Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Types

Subsegments:

1) By Surgery: Tumor Resection, Palliative Surgery, Laparoscopic Surgery, Amputation

2) By Radiology: Radiation Therapy, Stereotactic Radiosurgery, Brachytherapy, Imaging Techniques

3) By Chemotherapy: Injectable Chemotherapy, Oral Chemotherapy, Combination Chemotherapy Protocols, Targeted Therapy Agents

4) By Other Therapies: Immunotherapy, Photodynamic Therapy, Supportive Care, Alternative Therapies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=9533&type=smp

Which Regions Are Key Players in the Growth of the Veterinary Oncology Market?

The countries covered in the veterinary oncology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Are the Most Significant Market Trends in the Veterinary Oncology Market?

Leading entities in the veterinary oncology market are channeling their efforts towards the creation of neoantigens, exclusively tumor-specific antigens stemming from mutations in cancer-ridden cells. Unlike standard antigens present in healthy tissues, these neoantigens arise as a consequence of genetic alterations in the tumor’s DNA. An example of this can be seen in Biotechnology company, a US-based firm that embarked on a cancer vaccine trial for dogs in October 2024. The ambition behind developing neoantigens lies within the concept of cancer vaccines, along with other potential immunotherapies, with the objective to amplify immune reactions specifically against cancerous cells and simultaneously preserve regular cells.

View the full report here:

https://www.thebusinessresearchcompany.com/report/veterinary-oncology-global-market-report

What Parameters Are Used to Define the Veterinary Oncology Market?

Veterinary oncology refers to the diagnosis and treatment of cancer by specially trained experts to integrate cancer treatment with underlying conditions while sustaining a quality of life in animals. It deals with cancer medicine and treatment services in animals.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9533

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model